Distinct shells carrying a filed role for this person — not every shell they have ever touched.
SEC-verified vehicles of the same sponsor, predating these roles and carrying none of them. The badge counts them; the figure beside this one does not.
Mergers closed across all 2 — these vehicles and the franchise's earlier ones together.
Announced but not closed, and still hunting — again over all 2.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
none appears on more than one
Soumen Das, age 44, is a Sacramento, California-based SPAC executive and capital markets specialist who currently serves as Chief Financial Officer and Director of SPACSphere Acquisition Corporation, a blank check company incorporated in the Cayman Islands and headquartered at 8795 Folsom Blvd, Sacramento. He co-leads the SPAC alongside CEO and Chairman Bala Padmakumar, a seasoned SPAC sponsor. SPACSphere Acquisition filed its S-1 with the SEC on September 19, 2025, seeking to raise up to $150 million through the offering of 15 million units at $10.00 each, with each unit comprising one Class A ordinary share and one right to receive one-seventh of a share upon completion of an initial business combination. The company priced its IPO on February 5, 2026, and subsequently announced the closing of a $172.5 million initial public offering, with units trading on the Nasdaq under the symbol SSACU. D. Boral Capital served as sole bookrunner. The SPAC targets industries where its management team has core competencies, including digital assets, technology, and healthcare. In February 2026, SPACSphere filed its initial beneficial ownership statement listing Das as a director and 10% owner.
Prior to SPACSphere, Das served as Director of Capital Markets & Investments at VIKASA Capital Inc. from June 2021 to May 2024, where he also held the role of Managing Director of the VIKASA SPAC Series. In that capacity, he advised Stardust Power (SDST) on its merger with Global Partner Acquisition II. Earlier in his career, Das worked as a SPAC IPO Manager for Explorer LLC. His operating experience spans healthcare and technology companies: he has served as Director of Finance of Meditab Software Inc. since July 2024 and as Chief Financial Officer of DosePacker Inc. since May 2025, where he has been consolidating DosePacker as a technology company acquiring pharmacies and implementing its technology platform. From 2015 to 2018, he was the project development manager and chief financial officer of JENO RD. Das holds an M.B.A., and his track record reflects deep expertise across SPAC formation, IPO execution, capital markets advisory, and financial leadership in technology-driven healthcare businesses.
This record is keyed to SEC CIK 0002091020 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 11 institutional-holder rows on these vehicles, under 10 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.